Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -743.61 Million CNY | 4.78% |
| 2022 | -783.2 Million CNY | 7.63% |
| 2021 | -847.9 Million CNY | -32.89% |
| 2020 | -638.02 Million CNY | 56.2% |
| 2019 | -1.45 Billion CNY | -349.53% |
| 2018 | -291.52 Million CNY | -277.79% |
| 2017 | -85.78 Million CNY | 26.08% |
| 2016 | -116.04 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | -33.74 Million USD | -52.93% |
| 2023 Q4 | -34.7 Million USD | -2.86% |
| 2023 Q1 | -23.3 Million USD | 29.32% |
| 2023 FY | - CNY | 4.78% |
| 2023 Q2 | -22.06 Million USD | 5.35% |
| 2022 Q4 | -32.97 Million USD | -3.16% |
| 2022 Q2 | -57.42 Million USD | 0.0% |
| 2022 FY | - CNY | 7.63% |
| 2022 Q3 | -31.97 Million USD | 44.33% |
| 2021 Q2 | -56.73 Million USD | 0.0% |
| 2021 FY | - CNY | -32.89% |
| 2021 Q4 | -83.44 Million USD | 0.0% |
| 2020 FY | - CNY | 56.2% |
| 2020 Q2 | -42.25 Million USD | 0.0% |
| 2020 Q4 | -53.15 Million USD | 0.0% |
| 2019 Q2 | -35.1 Million USD | 0.0% |
| 2019 Q4 | -48.67 Million USD | 0.0% |
| 2019 FY | - CNY | -349.53% |
| 2018 FY | - CNY | -277.79% |
| 2017 FY | - CNY | 26.08% |
| 2016 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -946.807% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -12442.105% |
| SQZ Biotechnologies Company | -64.14 Million USD | -1059.336% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -4181.002% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 890.754% |
| Mesoblast Limited | -62.38 Million USD | -1091.879% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -48310.565% |
| Genus plc | 73.7 Million USD | 1108.969% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -11147.192% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -20864.489% |
| Marizyme, Inc. | -34.28 Million USD | -2069.131% |
| ContraFect Corporation | -64.99 Million USD | -1044.033% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -8377.086% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -16329.031% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -52946.494% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -28019.668% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -31899.466% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -143441.307% |
| Accustem Sciences Inc. | -3.74 Million USD | -19748.554% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -1441.896% |
| EV Biologics, Inc. | -1.26 Million USD | -58584.494% |
| Q BioMed Inc. | -617.62 Thousand USD | -120297.715% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 20917.749% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -117484.273% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -32450.387% |
| Biomind Labs Inc. | -1.03 Million USD | -71777.697% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 7628.703% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -10283.765% |
| Skye Bioscience, Inc. | -13.54 Million USD | -5388.889% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -49893.546% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -2974340.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -19043.891% |
| IMV Inc. | -35.52 Million USD | -1993.297% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -4585.711% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -29621.075% |
| GB Sciences, Inc. | -1.41 Million USD | -52271.143% |
| Alpha Cognition Inc. | -9.7 Million USD | -7561.658% |
| HST Global, Inc. | -5303.00 USD | -14022340.128% |
| CSL Limited | 4.78 Billion USD | 115.527% |
| Halberd Corporation | -74.27 Thousand USD | -1001003.946% |
| Enzolytics Inc. | -2.12 Million USD | -34942.405% |
| Resverlogix Corp. | -11.74 Million USD | -6232.908% |
| Affymax, Inc. | -14.29 Million USD | -5101.889% |
| SYBLEU INC | -141.57 Thousand USD | -525155.879% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -24177.052% |
| argenx SE | -216.02 Million USD | -244.227% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -1243.736% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 61201.89% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -49510.182% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 196383.959% |
| AVAX Technologies, Inc. | -6.11 Million USD | -12065.114% |
| Zenith Capital Corp. | -8.6 Million USD | -8540.6% |
| Genscript Biotech Corporation | -248.71 Million USD | -198.975% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -4268369.089% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -30295.334% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -422347.211% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -1776.057% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -25609.757% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -70969.624% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 11059142.237% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -42392.024% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -38611.32% |
| BioStem Technologies, Inc. | -7.55 Million USD | -9744.386% |
| ONE Bio Corp. | 13.61 Million USD | 5562.481% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -410534.609% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -36050.219% |
| Agentix Corp. | -1.37 Million USD | -54108.62% |
| LadRx Corporation | 412.28 Thousand USD | 180463.973% |
| Cell Source, Inc. | -4.27 Million USD | -17304.458% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -202396.589% |
| Regen BioPharma, Inc. | 1.46 Million USD | 50825.261% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -79265.045% |
| NovAccess Global Inc. | -1.03 Million USD | -71760.471% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 8498.766% |
| Itoco Inc. | -1.86 Million USD | -39686.623% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -195782.725% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -66531.72% |
| Kadimastem Ltd | -2.62 Million USD | -28234.682% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -310838.741% |
| CytoDyn Inc. | -18.02 Million USD | -4024.522% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -940833.075% |
| Mobile Lads Corp. | -2.24 Million USD | -33079.707% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -6080609.788% |
| Qrons Inc. | -40.08 Thousand USD | -1855168.082% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -153007.615% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 141086.628% |
| Rebus Holdings, Inc. | -951 Thousand USD | -78092.429% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -69919.115% |
| International Stem Cell Corporation | 202 Thousand USD | 368223.762% |
| Bioxytran, Inc. | -3.82 Million USD | -19365.481% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1412532.979% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -30104.327% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -1973.127% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -1652366.667% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -27058.875% |
| Neutra Corp. | -181.24 Thousand USD | -410174.377% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -3588.725% |
| PureTech Health plc | -11.62 Million USD | -6295.545% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -3588.978% |
| IXICO plc | -707 Thousand USD | -105078.218% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -9576.122% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -1438.1% |
| CSL Limited | 4.73 Billion USD | 115.711% |
| Cellectis S.A. | -92.63 Million USD | -702.722% |